Search for: "Corporal Holman"
Results 41 - 60
of 102
Sorted by Relevance
|
Sort by Date
15 Aug 2019, 6:22 am
Gompers is the Eugene Holman Professor of Business Administration at Harvard Business School; and Yuhai Xuan is Professor of Finance at the Gies College of Business at the University of Illinois at Urbana-Champaign. [read post]
27 Jul 2011, 1:01 am
Highlights this week included: Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Glybera (Alipogene tiparvovec) – EU: EMA continues to defer approval of first gene therapy application in Europe (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
30 Jun 2015, 9:17 pm
Attorneys Claire Fay and Michelle Holman Kerin are prosecuting the case. [read post]
28 Oct 2011, 6:43 am
So how did David Holman, counsel for Mabon Limited, turn this into something dramatic? [read post]
10 Aug 2022, 6:31 am
Gompers is Eugene Holman Professor of Business Administration at Harvard Business School; Steven N. [read post]
18 Nov 2010, 10:01 pm
Larry Ribstein from the blogosphere and Holman Jenkins from the financial media have been leaders over the past several years in exposing the Department of Justice's disingenuous campaign to criminalize the corporate compensation technique commonly known as backdating stock options. [read post]
10 Aug 2022, 6:31 am
Gompers is Eugene Holman Professor of Business Administration at Harvard Business School; Steven N. [read post]
26 Oct 2011, 2:30 am
Prometheus Labs (Patently-O) US: Pioneer-DuPont sues Monsanto for infringing “low tech” agricultural biotechnology patents (Holman’s Biotech IP Blog) Products Arzerra (Ofatumumab) / Rituxan (Rituximab)– US: Claim construction ruling in Arzerra infringement case: Biogen Idec and Genentech v. [read post]
22 Mar 2019, 12:13 pm
… Although [Craig Holman of Public Citizen] was initially optimistic when Trump issued his executive order, Holman said Wednesday, “It is now quite evident that the pledge was little more than campaign rhetoric. [read post]
22 Mar 2019, 12:13 pm
… Although [Craig Holman of Public Citizen] was initially optimistic when Trump issued his executive order, Holman said Wednesday, “It is now quite evident that the pledge was little more than campaign rhetoric. [read post]
4 Apr 2012, 9:20 am
The complaint alleges that Lupe Cardona, who was employed at AT&T as a corporate service representative in Indianapolis since 1984, asked for a finite leave of absence as a reasonable accommodation to get treatment for Hepatitis C. [read post]
7 Feb 2013, 6:20 am
United States, a challenge to the ban on direct corporate campaign spending in the Federal Campaign Finance Act, and McCutcheon v. [read post]
1 Apr 2011, 5:07 am
Guest speakers include Lori Andrews, Felix Wu, Ury Fischer, Chris Holman, and Robert Stoll. [read post]
6 Apr 2016, 4:06 am
Importantly, Professors Rebecca Eisenberg and Christopher Holman state that a possible explanation for this distinction by the U.S. [read post]
13 Feb 2009, 5:00 am
(Profitability through Simplicity) Patent World SPC round-up ‘Prolonging Patent Protection’ by Marjan Noor (SPC Blog) EU: Commission’s view on paediatric extensions (The SPC Blog) EU: Suing, not suing both attract the Commission’s attention – EU pharma inquiry (PatLit) EU: Life Science marks held confusingly similar: Bayern Innovativ – Bayerische Gesellschaft für Innovation und Wissenstransfer mbH, v Office for Harmonisation in the… [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US:… [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
18 Nov 2009, 4:57 am
(Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) US: Bio Podcast: The role of patents in a pathway for the approval of biosimilars (Holman's Biotech IP Blog) US: Lilly files principal brief for Ariad v Lilly rehearing en banc - Ariad Pharmaceuticals, Inc. v. [read post]
27 May 2009, 5:27 am
(Patent Office’s rejection of Glivec’s second variant) (Spicy IP) (Spicy IP) Sweden: Anti-counterfeit barcode technology trialled in Sweden (Managing Intellectual Property) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Inventive Step) (Holman's Biotech IP Blog) US: Biotech sector highly critical of… [read post]
